JHMI Office of Communications and Public Affairs

March 15, 1999

For press inquiriesonly, please call (410) 955-6680.

Johns Hopkins Singapore To Hold Cancer Symposium Marking Opening of Hopkins Research, Education and Clinical Services

Leading cancer specialists and other Johns Hopkins physicians and scientists will travel to Singapore for a symposium on April 17 held to celebrate the formal opening of Johns Hopkins Singapore (JHS) and Johns Hopkins Singapore Clinical Services (JHSCS), and its research, education and clinical services. The all-day event will be held at the Raffles City Convention Centre in the Westin Stamford Hotel. (Details of the program are attached.)

"We are bringing some of Hopkins' finest minds to this symposium to underscore the commitment of Johns Hopkins Medicine to Singapore and the health of its citizens," says Paul Lietman, M.D., Ph.D., Wellcome Professor of Clinical Pharmacology at Hopkins and director of JHS's research and educational activities. "We want to celebrate the creation of Johns Hopkins Singapore, but also to demonstrate that our activities in Singapore are very serious."

Established in January 1998, JHS gives Hopkins a professional and business presence in Asia and helps Singapore develop as a major regional biomedical hub. Under terms of the agreement establishing JHS, Hopkins is the sole owner of JHS and will retain managerial control of the organization and its medical operations, including quality control.

Also as part of the agreement, JHS Clinical Services Pte. Ltd. (JHSCS) was established to provide health care services in Singapore for complex medical conditions.

According to Steven J. Thompson, Johns Hopkins Medicine's vice dean for administration and CEO of both JHS and JHSCS, the oncology seminar marks the first of a series of initiatives to address the unique health concerns of citizens of Singapore and Southeast Asia. "We can look forward to a wide range of research, educational and clinical programs and activities all designed to make Singapore the medical hub of the region while forging a real partnership with physicians in the region for the benefit of all."

"Johns Hopkins Singapore gives us the opportunity to bring to the region the Hopkins brand of education, research and medicine," said Edward D. Miller, M.D., Johns Hopkins Medicine CEO and dean of The Johns Hopkins University School of Medicine. "While both Hopkins and Singapore have much to gain, ultimately, it is patients who will derive the greatest benefit from this exciting partnership."

The JHSCS partnership, which includes Singapore's Economic Development Board Investments (EDBI), VISTA Healthcare, Arcasia Land and Johns Hopkins International LLC, also calls for establishing partnerships with regional universities, multinational corporations, insurance companies and referring physician networks in Asia, as well as forming satellite centers in the region.

Unlike most arrangements between U.S.-based medical centers and foreign facilities, JHSCS follows a "center of excellence" model that places emphasis on research and medical education, as well as direct patient care, within a collaborative structure that benefits all participating organizations.

Johns Hopkins Medicine, a $1.8 billion enterprise that unites Hopkins' biomedical research, clinical, teaching and business enterprises, includes The Johns Hopkins University School of Medicine, three acute care hospitals -- The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center and Howard County General Hospital -- and all other aspects of an integrated health care delivery system, from community clinics to long-term care and home care. Every year since 1991, U.S. News & World Report has ranked The Johns Hopkins Hospital as the best hospital in America, and the U.S. National Institutes of Health (NIH) has awarded Hopkins scientists more research funding than faculty at any other medical school.

Trends in Oncology
17 April 1999

Hopkins specialists presenting the latest research in oncology are Michael Choti, M.D., assistant professor of surgery and oncology; Nancy Davidson, M.D., associate professor of oncology; William Schlott, M.D., associate professor of medicine, and Richard Ambinder, M.D., Ph.D., director of the Hopkins Lymphoma Program and director of the Virology Laboratory at Johns Hopkins Singapore. Hopkins experts affiliated with Johns Hopkins Singapore who will speak at the symposium include Lietman; Enser Cole, M.D., assistant oncology program director at JHS; Daniel Chan, Ph.D., associate professor of pathology; Alex Chang, M.D., director of Johns Hopkins Singapore Clinical Services and Kam Leong, Ph.D., associate professor in biomedical engineering.

Other speakers at the symposium include Soo Kee Chee, M.D., director of Singapore's National Cancer Centre, and John Wong, M.D., associate professor of oncology at the National University Hospital in Singapore.

Topics to be presented include:

Other ongoing projects at JHS include:

Health care professionals who wish to register for this symposium should contact:

The Secretary, Johns Hopkins Singapore Symposium
Johns Hopkins Singapore Pte Ltd
Clinical Research Centre (MD-11)
10 Kent Ridge Crescent, Singapore 119260
Tel (65) 874 7603 Fax (65) 773 5647
Email: pgomez@jhs.com.sg

Related Web Sites: Johns Hopkins International Services: http://www.med.jhu.edu/international

-- JHMI --
Search Press Releases

News Media Home | Hopkins Medicine Home